Overview Financials News + Filings Key Docs Charts Ownership Insiders
|
Greenwich LifeSciences, Inc. (GLSI)
|
|
Balance Sheet |
|
|
|
Standardized | As Reported |
Annual | Quarterly |
|
In millions, except per share items | Jun-30-23 | Dec-31-22 | Sep-30-22 | Jun-30-22 | Mar-31-22 | Dec-31-21 | Jun-30-21 | Mar-31-21 |
| 10-Q | 10-K | 10-Q | 10-Q | 10-Q | 10-K | 10-Q | 10-Q |
Assets |
Cash and equivalents | 10.9 | 13.5 | 15.6 | 17.2 | 19.7 | 27.2 | 29.8 | 30.4 |
Total current assets | 10.9 | 13.5 | 15.6 | 17.2 | 19.7 | 27.2 | 29.8 | 30.4 |
Intangibles | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
Total assets | 11.0 | 13.5 | 15.6 | 17.2 | 19.8 | 27.2 | 29.8 | 30.4 |
|
Accrued expenses | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.2 | 0.0 | 0.1 |
Short-term debt | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
Other current liabilities | 0.3 | 0.2 | 0.2 | 0.2 | 0.2 | 0.2 | 0.6 | 0.6 |
Total current liabilities | 0.3 | 0.3 | 0.2 | 0.2 | 0.2 | 0.4 | 0.7 | 0.7 |
Total liabilities | 0.3 | 0.3 | 0.2 | 0.2 | 0.2 | 0.4 | 0.7 | 0.7 |
|
Shareholders' equity [+] | 10.6 | 13.2 | 15.4 | 17.0 | 19.5 | 26.8 | 29.2 | 29.7 |
Paid-in capital | 55.9 | 54.7 | 54.1 | 53.3 | 55.1 | 60.5 | 59.6 | 59.4 |
Retained earnings | -45.2 | -41.5 | -38.7 | -36.4 | -35.6 | -33.6 | -30.4 | -29.7 |
Tangible shareholders' equity | 10.6 | 13.2 | 15.4 | 17.0 | 19.5 | 26.8 | 29.1 | 29.7 |
|